Eric Schoenmakers, PhD

Vice President, Pre-Clinical Programs and Therapeutics Development

Eric most recently enjoyed a role as “Employee #2” and Head of Preclinical Development and Analytical Sciences at Biomea Health, LLC, a Bay Area Oncology Biotech startup that recently closed a $56M series A financing. Before that he served as a Director Clinical Genetics within the Translational Medicine team at AbbVie / Pharmacyclics, Inc. Prior to joining Pharmacyclics, Eric headed the Pfizer Oncology Clinical Research Laboratory at Pfizer’s Global R&D site in La Jolla, CA.

Eric started his career in academia, and was a tenured faculty member at the Department of Human Genetics in Nijmegen, The Netherlands for over a decade. He earned a MSc. in Biology (with majors in Molecular Biology, Genetics, and Immunology) at the University of Nijmegen, The Netherlands, and a summa cum laude doctorate in Human (Cancer) Genetics from the University of Leuven, Belgium. He has been awarded several US and international patents in the field of tumorigenesis and diagnostics, co-authored over a hundred peer-reviewed publications in top-tier, international journals including Nature Genetics and the Journal of Clinical Oncology, and has been a scientific grant reviewer for over a dozen scientific organizations worldwide.